β-Elemene alleviates cisplatin resistance in oral squamous cell carcinoma cell via inhibiting JAK2/STAT3 pathway in vitro and in vivo
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-Elemene alleviates cisplatin resistance in oral squamous cell carcinoma cell via inhibiting JAK2/STAT3 pathway in vitro and in vivo
Authors
Keywords
-
Journal
Cancer Cell International
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-31
DOI
10.1186/s12935-022-02650-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway
- (2020) Tonglin Hu et al. BIOSCIENCE REPORTS
- EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling
- (2020) Xiang Song et al. Cancer Management and Research
- β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT
- (2020) Yufei Liang et al. ACTA HISTOCHEMICA
- β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways
- (2020) Pengyu Su et al. OncoTargets and Therapy
- β-Elemene Enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial–mesenchymal transition and cancer-stewm cell traits via Prx-1/NF-kB/iNOS signaling pathway
- (2020) Kun Zou et al. Aging-US
- Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
- (2019) Cheng-cheng Zhang et al. APOPTOSIS
- Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers
- (2019) Chengsong Cao et al. Drug Design Development and Therapy
- Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review
- (2019) Bingtao Zhai et al. BIOMEDICINE & PHARMACOTHERAPY
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Multi-Targeting by β-Elemene and Its Anticancer Properties: A Good Choice for Oncotherapy and Radiochemotherapy Sensitization
- (2019) Hongxuan Tong et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles
- (2019) Xin-Hui Khoo et al. Cancers
- Progress in targeted therapeutic drugs for oral squamous cell carcinoma
- (2019) Lian Liu et al. SURGICAL ONCOLOGY-OXFORD
- Cisplatin nephrotoxicity: a review of the literature
- (2017) Sandhya Manohar et al. JOURNAL OF NEPHROLOGY
- WITHDRAWN: Elemene Increases Autophagic Apoptosis and Drug Sensitivity in Human Cisplatin (DDP)-Resistant Lung Cancer Cell Line SPC-A-1/DDP By Inducing Beclin-1 Expression
- (2017) Kun Zhou et al. ONCOLOGY RESEARCH
- Beta-elemene treatment is associated with improved outcomes of patients with esophageal squamous cell carcinoma
- (2017) Zhiwei Chang et al. SURGICAL ONCOLOGY-OXFORD
- Synergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway
- (2017) Chengyi Huang et al. MEDICAL SCIENCE MONITOR
- LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression
- (2017) Zheng Fang et al. Cancer Medicine
- Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells
- (2017) JingJing Wu et al. Scientific Reports
- A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2
- (2016) Kristian Jensen et al. MODERN PATHOLOGY
- Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells
- (2012) Qingdi Quentin Li et al. MEDICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started